Revenue | ₹88.85Cr |
Net Profits | ₹1.29Cr |
Net Profit Margins | 1.45% |
Mangalam Drugs and Organics Ltd’s revenue fell -8.72% since last year same period to ₹88.85Cr in the Q3 2024-2025. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated 10.95% jump in its revenue since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit jumped 158% since last year same period to ₹1.29Cr in the Q3 2024-2025. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -52.04% fall in its net profits since last 3-months.
Mangalam Drugs and Organics Ltd’s net profit margin jumped 182.65% since last year same period to 1.45% in the Q3 2024-2025. On a quarterly growth basis, Mangalam Drugs and Organics Ltd has generated -56.78% fall in its net profit margins since last 3-months.
The revenue for Mangalam Drugs and Organics Ltd in the Q3 results 2024 was ₹88.85Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q3 results 2024 was ₹1.29Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q3 results 2024 was 1.45%.
The revenue for Mangalam Drugs and Organics Ltd in the Q3 results 2023 was ₹97.34Cr.
The net profit for Mangalam Drugs and Organics Ltd in the Q3 results 2023 was ₹0.50Cr.
The net profit margin for Mangalam Drugs and Organics Ltd in the Q3 results 2023 was 0.51%.